RecruitingNCT07558564

Evaluation of Platelet-Rich Plasma (PRP) Treatment in Tendinopathies

Studying Rapidly involuting congenital hemangioma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
ReSport Clinic
Principal Investigator
Ferran Abat Gonzalez, MD PhD
ReSport Clinic
Intervention
Platelet rich plasma (PRP)(biological)
Enrollment
2000 target
Eligibility
18 years · All sexes
Timeline
20262028

Study locations (5)

Collaborators

BioSmartData

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07558564 on ClinicalTrials.gov

Other trials for Rapidly involuting congenital hemangioma

Additional recruiting or active studies for the same condition.

See all trials for Rapidly involuting congenital hemangioma

← Back to all trials